patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: patientman..re Frank Carlucci..common sense, Carlucci did not buy

Nov 08, 2007 04:54AM

Nov 08, 2007 05:08AM

Nov 08, 2007 05:13AM
4.1% of this company to have it remain an otc stock, lol..trust me
Share
New Message
Please login to post a reply